Advertisement

Topics

Man Receives First In Vivo Gene-Editing Therapy

03:52 EST 15 Nov 2017 | The Scientist

The 44-year-old patient has Hunter syndrome, which doctors hope to treat using zinc finger nucleases.

Original Article: Man Receives First In Vivo Gene-Editing Therapy

NEXT ARTICLE

More From BioPortfolio on "Man Receives First In Vivo Gene-Editing Therapy"

Advertisement
Quick Search
Advertisement
Advertisement